Concepedia

Treatment satisfaction across injectable, infusion, and oral disease-modifying therapies for multiple sclerosis

Tessa Eagle, Fiona Stuart, Alicia S. Chua, Allison LaRussa, Kaitlynne N. Leclaire, Sandra L. Cook, Tanuja Chitnis, Howard L. Weiner, Bonnie I. Glanz, Brian C. Healy

Multiple Sclerosis and Related Disorders · 2017 · 18 citations · 15 references

DOI

Concepts

References

15

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

, , +14

Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity

Paul Browne, Dhia Chandraratna, Ceri Angood et al. · Neurology · 2014 · 1.2K citations · Full text

, , +7

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease.

Mark J. Atkinson, Anusha Sinha, Steven Hass et al. · Health and Quality of Life Outcomes · 2004 · 996 citations · Full text

, , +16

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

Ludwig Kappos, David Li, Peter A. Calabresi et al. · The Lancet · 2011 · 741 citations

, , +8

Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis

Stephanie C. Steinberg, Richard Faris, Cyril F. Chang et al. · Clinical Drug Investigation · 2010 · 245 citations

, , +11